Average Co-Inventor Count = 5.69
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. University Health Network (33 from 291 patents)
2. Aventis Pharmaceuticals Inc. (2 from 207 patents)
3. Rhone-poulenc Rorer Pharmaceuticals Inc. (2 from 111 patents)
4. Affinium Pharmaceuticals, Inc. (2 from 33 patents)
5. Debiopharm International, S.a. (2 from 20 patents)
6. Aventis Pharma Deutschland, Gmbh (1 from 330 patents)
7. Aventis Pharmaceuticals Products Inc. (1 from 23 patents)
44 patents:
1. 12473283 - Compounds and their use
2. 11878980 - Solid forms of TTK inhibitor
3. 11667627 - Salt and crystal forms of PLK-4 inhibitor
4. 11104681 - Solid forms of TTK inhibitor
5. 11059832 - HPK1 inhibitors and methods of using same
6. 10919886 - Salt and crystal forms of PLK-4 inhibitor
7. 10875863 - RIPK2 inhibitors and method of treating cancer with same
8. 10584130 - Solid forms of TTK inhibitor
9. 10570143 - Pyrazolopyrimidine compounds
10. 10501474 - HPK1 inhibitors and methods of using same
11. RE47731 - Kinase inhibitors and method of treating cancer with same
12. 10472353 - Salt and crystal forms of PLK-4 inhibitor
13. 10392374 - Salt and crystal forms of PLK-4 inhibitor
14. 10358436 - Kinase inhibitors and method of treating cancer
15. 10239881 - RIPK2 inhibitors and method of treating cancer with same